Choosing a new treatment for depression is an important decision, and it’s natural to have questions along the way. If you’ve been researching options for treatment-resistant depression, you’ve likely come across both Spravato and IV ketamine therapy.
Because these treatments are related, they are often discussed together, but they are not the same. Understanding their differences can help you feel more confident as you explore your options.
In this Spravato vs IV ketamine guide, we’ll provide a clear depression treatment comparison, explaining how each treatment works, who may be a candidate, and what to expect.
Because Hexis Healthcare offers both Spravato and IV ketamine therapy, our providers can recommend the treatment that best fits your needs and not just the one that’s available.
Why Are People Comparing Spravato and IV Ketamine?
It’s easy to see why Spravato and IV ketamine are often compared. Both treatments are derived from ketamine and have become promising options for people whose depression hasn’t improved with traditional antidepressants.
Another similarity is that both Spravato treatment and ketamine therapy for depression are administered under the supervision of trained medical professionals. This ensures patients receive appropriate care in a safe, monitored environment throughout each appointment.
While these treatments have a great deal in common, they also have important differences that may influence which option is most appropriate for a particular person. Factors such as FDA approval, how the treatment is administered, insurance coverage, and individual health needs all play a role. Understanding these distinctions is an important first step in determining which treatment may be the best fit for your unique situation.
Spravato vs. IV Ketamine: What’s the Difference?
When comparing Spravato and IV ketamine, it’s helpful to remember that while the treatments are related, they are not identical. Both are used to help people with treatment-resistant depression, but they differ in how they’re made, how they’re administered, and how they’re approved for use.
Where Spravato is an FDA-approved nasal spray containing esketamine, IV ketamine therapy delivers ketamine through an intravenous infusion (IV) and is prescribed off-label for depression.
Rather than asking which treatment is “better,” it’s more helpful to ask which treatment is the better fit for you. Factors like your medical history, previous treatments, symptoms, and insurance coverage can all help determine the most appropriate treatment plan.
How Treatment Experience Differs
While both treatments are provided in a safe, medically-supervised setting, the experience of receiving them is a bit different.
With Spravato treatment, you’ll self-administer a nasal spray under the guidance of your healthcare team. Afterward, you’ll remain at the clinic for a monitored observation period to ensure you’re feeling well before returning home. Treatment typically begins with two appointments per week for the first month, followed by a reduced schedule based on your progress and your provider’s recommendations.
IV ketamine therapy is administered through an intravenous (IV) infusion while you relax in a comfortable treatment room. Like Spravato, you’ll be monitored throughout your appointment and observed afterward to ensure your safety. The number and frequency of infusions can vary depending on your individual treatment plan and response.
Because both treatments can temporarily affect alertness, patients need to arrange for someone else to drive them home after each appointment.
Insurance Coverage and Cost Considerations
When comparing treatment options, cost and insurance coverage are often important factors. Because Spravato treatment is FDA-approved for adults with treatment-resistant depression, many insurance plans may provide coverage for patients who meet specific eligibility requirements. However, coverage can vary depending on your provider and individual plan.
IV ketamine therapy is different. While ketamine has been safely used in medical settings for decades, its use in treating depression is considered off-label, meaning it has not been FDA-approved specifically for that purpose. Even so, IV ketamine is a well-established treatment option that many healthcare providers offer for patients with treatment-resistant depression. Because of its off-label status, insurance coverage is often more limited.
As with any depression treatment comparison, it’s best to verify your benefits before beginning care. At Hexis Healthcare, our team is happy to answer questions about treatment costs and help you understand your available options so you can make an informed decision.
Which Treatment May Be Right for You?
When it comes to comparing Spravato and IV Ketamine, there isn’t a one-size-fits-all answer. Every person’s experience with depression is different, so the most appropriate treatment depends on your unique symptoms, medical history, treatment goals, and individual needs.
In some cases, a provider may recommend Spravato because it’s FDA-approved and may be covered by insurance. In other situations, IV ketamine therapy may be a better fit based on a patient’s medical history, previous response to treatment, or other clinical considerations. Your healthcare provider will also consider factors such as your experience with antidepressants, overall health, and personal preferences to determine the most appropriate course of care.
At Hexis Healthcare, we believe personalized care leads to better outcomes. That’s why we begin with a thorough evaluation, taking the time to understand your concerns before developing an individualized treatment plan. Through collaborative decision-making and a holistic approach to care, our team is committed to helping you find a treatment option that supports your long-term mental health and overall well-being.
Final Thoughts – Personalized Care Starts with the Right Conversation
Both Spravato treatment and IV ketamine therapy have helped many people find relief from treatment-resistant depression when traditional approaches were no longer enough. While learning about Spravato and IV Ketamine is an important first step, the best treatment choice can only be made through a thorough evaluation of your unique health history, symptoms, and goals.
If you’re still deciding between Spravato and IV ketamine, you don’t have to make that decision alone. Schedule a consultation with Hexis Healthcare today to meet with our team and determine which treatment best fits your unique needs and goals.
Frequently Asked Questions About Spravato vs. IV Ketamine
Are Spravato and IV ketamine the same treatment?
No. While both treatments are derived from ketamine and are used to help individuals with treatment-resistant depression, they are not the same. Spravato contains esketamine and is administered as a nasal spray, while IV ketamine therapy delivers ketamine through an intravenous infusion. Both treatments are provided under medical supervision but differ in FDA approval, administration, and insurance coverage.
Is Spravato or IV ketamine more effective?
There isn’t a single answer to this question. Both treatments have helped many people find relief from depression, but each person’s response is different. The most appropriate treatment depends on factors such as your medical history, previous antidepressant use, symptoms, treatment goals, and your healthcare provider’s recommendations.
How do I know if I’m a candidate for Spravato or IV ketamine therapy?
The best way to determine whether Spravato or IV ketamine therapy is right for you is through a comprehensive evaluation with a qualified healthcare provider. At Hexis Healthcare, we take the time to review your medical history, previous treatments, current symptoms, and overall health before recommending a personalized treatment plan.
Can I switch from IV ketamine to Spravato or vice versa?
It all depends on your unique situation. A healthcare provider may recommend transitioning from one treatment to another based on your response to therapy, changes in your symptoms, insurance coverage, or other medical considerations. If your current treatment isn’t providing the results you hoped for, talk with your provider about whether another option may be appropriate.
